HIV Alert: Emerging Updates on Dual Therapy

In this downloadable slideset, Joseph J. Eron, Jr., MD, and Babafemi Taiwo, MBBS, provide expert insight into the use of a recently-approved dual-therapy regimen and review data surrounding investigational two-drug regimens.
Format: Microsoft PowerPoint (.ppt)
File Size: 375 KB
Released: January 5, 2018


Educational grant provided by:
ViiV Healthcare

Related Content

Week 96 data from GS-US-380-1489 study of BIC/FTC/TAF vs DTG/ABC/3TC in treatment-naive adults presented at IDWeek 2018 reported by Clinical Care Options

Released: October 17, 2018

Phase III data from DRIVE-SHIFT on switch to doravirine/lamivudine/tenofovir DF vs continued baseline ART in virologically suppressed patients presented at IDWeek 2018 reported by Clinical Care Options

Released: October 17, 2018

Week 96 efficacy, safety data on doravirine/lamivudine/tenofovir DF as first-line ART from DRIVE-AHEAD as presented at IDWeek 2018 and reported by Clinical Care Options (CCO)

Released: October 17, 2018

Drs. Eric S. Daar and Chloe Orkin provide official CME-certified Conference Coverage from the 2018 International AIDS Conference (AIDS 2018).

Eric S. Daar, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.7 Nursing contact hours Released: October 3, 2018 Expiration: October 2, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?